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Background:  Stable plasma nitric oxide metabolites (NOx), predominantly composed of nitrate, are markers of endogenous nitric oxide 
(NO) production, NO utilization, and dietary intake and may be indicators of vascular health.
methods:  We enrolled subjects undergoing a clinically-indicated cardiac MRI. Plasma NOx levels were determined after reduction to NO 
via the reaction with vanadium(III)/hydrochloric acid. NO was quantified by its gas phase chemiluminescence reaction with ozone. Levels 
were quantified using a standard curve generated with nitrate. Due to skewed distributions, NOx levels were log-transformed. ANOVA 
models were created comparing NOx levels between groups, with adjustment for multiple comparisons.
results:  Subjects with HFpEF had lower NOx levels than both HFrEF and HTN subjects.
n Geometric Mean NOx
 (95% CI) Bonferroni-Corrected Comparison
HFrEF 28 13.41 (9.34-19.25) HFrEF HFpEF
HTN 75 11.02 (9.12-13.31) HFpEF 0.008
HFpEF 47 7.07 (5.37-9.31) HTN 0.95 0.02
Overall P=0.004
conclusion:  HFpEF subjects had significantly lower NOx levels, suggesting greater endothelial dysfunction, enhanced clearance, or 
deficient dietary ingestion. Low plasma NOx may contribute to the impaired vasodilatory reserve in HFpEF, since inorganic nitrate/nitrite are 
mediators of hypoxic vasodilation. Whether nitrate supplementation is beneficial in HFpEF should be investigated in future trials.
